Novo Nordisk
(NYSE) NVO
Novo Nordisk Financials at a Glance
Market Cap
$124.93B
Revenue (TTM)
$308.35B
Net Income (TTM)
$102.19B
EPS (TTM)
$3.47
P/E Ratio
10.68
Dividend
$1.73
Beta (Volatility)
0.69 (Low)
Dividend
$1.73
Beta (Volatility)
0.69 (Low)
Price
$36.55
Volume
35,404
Open
$36.52
Price
$36.55
Volume
35,404
Open
$36.52
Previous Close
$37.08
Daily Range
$36.32 - $36.57
52-Week Range
$35.85 - $81.44
Dividend
$1.73
Beta (Volatility)
0.69 (Low)
Price
$36.55
Volume
35,404
Open
$36.52
Previous Close
$37.08
Daily Range
$36.32 - $36.57
52-Week Range
$35.85 - $81.44
NVO News
NVO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Novo Nordisk
Industry
Pharmaceuticals
Sector
Health CareEmployees
68,794
CEO
Maziar Mike Doustdar
Website
www.novonordisk.comHeadquarters
Bagsvaerd, 2880, DK
NVO Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
41%
Net Income Margin
33%
Return on Equity
61%
Return on Capital
39%
Return on Assets
19%
Earnings Yield
9.36%
Dividend Yield
0.05%
Payout Ratio
50.53%
Stock Overview
Market Cap
$124.93B
Shares Outstanding
3.37B
Volume
35.40K
Short Interest
0.00%
Avg. Volume
24.77M
Financials (TTM)
Gross Profit
$238.77B
Operating Income
$129.83B
EBITDA
$143.94B
Operating Cash Flow
$119.10B
Capital Expenditure
$90.11B
Free Cash Flow
$28.99B
Cash & ST Invst.
$26.96B
Total Debt
$130.96B
Novo Nordisk Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$78.43B
-8.5%
Gross Profit
$63.42B
-12.7%
Gross Margin
80.86%
N/A
Market Cap
$124.93B
N/A
Market Cap/Employee
$1.61M
N/A
Employees
77,406
N/A
Net Income
$26.65B
-5.6%
EBITDA
$37.14B
-7.8%
Quarterly Fundamentals
Net Cash
$104.00B
-36.0%
Accounts Receivable
$75.70B
-13.4%
Inventory
$49.62B
+21.5%
Long Term Debt
$118.94B
+32.6%
Short Term Debt
$12.02B
-8.4%
Return on Assets
18.87%
N/A
Return on Invested Capital
39.01%
N/A
Free Cash Flow
$10.81B
-153.9%
Operating Cash Flow
$7.62B
-38.1%